Related Experiment Video

Updated: Jun 21, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

HCV reinfection studies and the door to vaccine development

Jason Grebely, David L Thomas, Gregory J Dore

    Journal of Hepatology
    |August 8, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Protocol for Analyzing Hepatitis C Virus Replication
    13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
    10:03

    Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

    Published on: August 1, 2013

    Related Experiment Videos

    Last Updated: Jun 21, 2026

    Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
    16:49

    Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

    Published on: July 16, 2012

    A Protocol for Analyzing Hepatitis C Virus Replication
    13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
    10:03

    Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

    Published on: August 1, 2013

    Related Concept Videos

    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

    Articles linked to this work by shared authors, journal, and citation graph.

    Read-Level Error Characterization of Rolling-Circle Amplification-Based Nanopore Sequencing of the Circular DNA Virome.

    Viruses·2026

    A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C Trial.

    Journal of hepatology·2026

    Prospective Study of Multiparametric Renal MRI for CKD Progression (AFiRM).

    Kidney international reports·2026

    Fast segmentation with the NextBrain histological atlas.

    Imaging neuroscience (Cambridge, Mass.)·2026

    Real-Time, Inline Quantitative MRI Enabled by Scanner-Integrated Machine Learning: A Proof of Principle With NODDI.

    Magnetic resonance in medicine·2026

    Updated hepatitis D seroprevalence among HBsAg-positive persons aged ≥6 years in the United States, National Health and Nutrition Examination Survey, 2007‒2018.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

    Spleen stiffness measurement rules out high-risk varices in patients with chronic portal vein thrombosis without cirrhosis.

    Journal of hepatology·2026

    Serum HBsAg cannot distinguish cccDNA activity from integrated HBV DNA expression in chronic hepatitis B virus infection.

    Journal of hepatology·2026

    Elafibranor in primary biliary cholangitis: two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE® phase III trial.

    Journal of hepatology·2026

    Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry.

    Journal of hepatology·2026

    Alcohol, Cardiometabolic Risk Factors, and Cirrhosis: Ten-Year Risk Estimates from a Population-based Danish Cohort.

    Journal of hepatology·2026

    Baveno VIII - Advancing Consensus in Portal Hypertension.

    Journal of hepatology·2026

    Electrochemical determination of terbutaline using a SnO2 nanoparticle-modified carbon paste electrode.

    Turkish journal of chemistry·2026

    Treatment of Congenital Cytomegalovirus Beyond the Neonatal Period: A Single-Arm Meta-Analysis.

    The Laryngoscope·2026

    Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

    The Journal of rheumatology·2026

    Molecular and Developmental Integrity Following Trophectoderm Biopsy: Evidence from Human and Mouse Models.

    F&S science·2026

    Involvement of NOD1/NF-κB/MAPK pathway in the protective effect of procyanidin B2 against methotrexate-induced nephrotoxicity.

    Science progress·2026

    Synergistic Photodynamic Antimicrobial Therapy Using 405 nm Laser Diode and Moringa Oleifera-Derived Silver Nanoparticles against Pathogenic Bacteria.

    Journal of lasers in medical sciences·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us